ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

BDSX vs FLGT // ENTERPRISE SCALE & MARKET CAP

Biodesix Inc. (NASDAQ) VS. Fulgent Genetics Inc. (NASDAQ) • 15-METRIC TALLY: BDSX 3 — FLGT 5
▲ ENTERPRISE SCALE & MARKET CAP LEADER: FLGT
market-cap
$245.4M
market-cap
$567.4M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BDSX VS. FLGT) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC BDSX FLGT SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 40.60% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -6.80% -28.20 FLGT /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -9.02% -20.82% +11.80 BDSX /fcf-yield <GO>
Operating Margin -31.50% -28.20% -3.30 FLGT /operating-margins <GO>
Net Profit Margin -39.90% -18.80% -21.10 FLGT /net-margins <GO>
Revenue Growth (YoY) 24.10% 13.80% +10.30 BDSX /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 4.44 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 3/9 +1.00 BDSX /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 44.9 48.3 -3.40 FLGT /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap ACTIVE $245.4M $567.4M -$322.0M FLGT /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR BDSX REV FLGT REV BDSX GROSS % FLGT GROSS % BDSX FCF FLGT FCF
FY 2025 $88.5M $322.7M — 40.6% -$23.5M -$124.2M
FY 2024 $71.3M $283.5M — 37.8% -$51.9M -$19.3M
FY 2023 $49.1M $289.2M — — -$22.9M $27.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BDSX // BETA —
FLGT // BETA —